Nestmedic S.A. is a leading Polish medical technology company specializing in telemedicine solutions aimed at enhancing fetal well-being monitoring. Founded in 2017, Nestmedic is based in Warsaw, Poland, and is recognized for its innovative approach to medical diagnostics, particularly through its flagship product, the Pregnabit system.
Vision and Mission
Nestmedic’s mission is to provide accessible, reliable, and user-friendly healthcare solutions that empower pregnant women to monitor their health independently. By integrating modern technology into maternal care, Nestmedic aims to transform the experience of prenatal diagnostics into a more efficient and stress-free process.
Key Products and Technologies
Pregnabit System:
- A mobile telemedicine solution for remote cardiotocography (KTG), which allows pregnant women to conduct essential fetal health monitoring from home.
- The system includes:
- A fetal heart rate probe
- A wrist heart rate monitor for measuring the mother’s pulse
- A tocodynamometer to assess uterine contractions
- Wireless transmission of results to a Medical Telemonitoring Center (MTC), where medical data is analyzed by healthcare professionals.
Business Model
Nestmedic operates in the growing telemedicine sector, providing services that do not require specialist assistance for routine monitoring. This model is aimed at reducing healthcare burdens and ensuring that women have continuous access to medical oversight during pregnancy.
Market Applications
The company’s solutions cater specifically to maternal and fetal health markets, emphasizing the importance of early detection and continuous monitoring. By using innovative technology, Nestmedic positions itself as a crucial player in ensuring better outcomes for mothers and babies.
Achievements and Recognition
Nestmedic has achieved significant milestones, including obtaining the Medical Device Regulation (MDR) certification for its Pregnabit system. The company has also established partnerships for distribution, notably with ScanMed A/S for the Scandinavian healthcare market, expanding its reach and impact.
Financial Overview
As of December 2025, Nestmedic reported an annual revenue of PLN 1.02 million, although it has faced challenges, recording a net loss of PLN 4.37 million. The company actively seeks growth opportunities and investments to bolster its innovative endeavors.
Future Goals
Nestmedic is focused on research and development to enhance the functionality of its existing products and to introduce new services that cater to the maternal healthcare sector. By leveraging technological advancements, the company aims to broaden its impact on prenatal health monitoring in Poland and beyond.
Conclusion
Nestmedic S.A. stands at the forefront of telemedicine in Poland, offering solutions that empower women and improve fetal monitoring processes. With its commitment to innovation and customer-centric healthcare, Nestmedic is set to play a crucial role in shaping the future of maternal health.
Company info:
ul. Pasymska 20
WARSZAWA, 01-993, Poland
Contact Information: +48 (71) 7575708
Industry: Medical Diagnostic & Testing Equipment